BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15726536)

  • 1. The importance of chemotherapy dose intensity in lung cancer.
    Crawford J
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):25-31. PubMed ID: 15726536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives in the treatment of colorectal cancer.
    Ozer H; Diasio RB
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):14-8. PubMed ID: 15726534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
    Avery EJ; Kessinger A; Ganti AK
    Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of pulmonary neoplasms].
    Crinò L; Calandri C
    Recenti Prog Med; 2001 Feb; 92(2):133-6. PubMed ID: 11294106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung cancer: strategies to optimize chemotherapy response.
    Psyrri A; Murren J
    Cancer J; 2001; 7 Suppl 1():S28-34. PubMed ID: 11504283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials.
    Sekine I; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N
    Cancer Treat Rev; 2004 Jun; 30(4):359-68. PubMed ID: 15145510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose intensity of chemotherapy in small-cell lung carcinoma].
    Borg C; Ligneau B; Trillet-Lenoir V
    Bull Cancer; 2001 Sep; 88(9):863-70. PubMed ID: 11604359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
    Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z; Xu F; Wang S; Li N; Wang C
    Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
    J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses.
    Crivellari G; Monfardini S; Stragliotto S; Marino D; Aversa SM
    Oncologist; 2007 Jan; 12(1):79-89. PubMed ID: 17227903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of chemotherapy dose and schedule to outcomes in ovarian cancer.
    Muggia FM
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):19-24. PubMed ID: 15726535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
    Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
    Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.